Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002342653 | SCV002640906 | pathogenic | Hereditary cancer-predisposing syndrome | 2015-02-06 | criteria provided, single submitter | clinical testing | The c.493-6_511del25 pathogenic mutation spans the last six nucleotides of intron 5 through the first 19 nucleotides of coding exon 6 in the PTEN gene. This pathogenic mutation results in a deletion of 25 nucleotides and disrupts the exon 6 splice acceptor site. Since mutations that disrupt the canonical splice acceptor site are typically deleterious in nature, this alteration is interpreted as a disease-causing mutation (ACMG recommendations for Standards for Interpretation and Reporting of Sequence Variations. Revision 2007. Genet Med. 2008;10:294). |